Budesonide-Loaded Bilosomes as a Targeted Delivery Therapeutic Approach Against Acute Lung Injury in Rats

Budesonide (BUD), a glucocorticoids drug, inhibits all steps in the inflammatory response. It can reduce and treat inflammation and other symptoms associated with acute lung injury such as COVID-19. Loading BUD into bilosomes could boost its therapeutic activity, and lessen its frequent administrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Salem, Heba F., Moubarak, Ghada Abdelsabour, Ali, Adel A., Salama, Abeer A.A., Salama, Alaa H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of American Pharmacists Association. 2023
Materias:
Pharmaceutics, Drug Delivery and Pharmaceutical Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549718/
https://www.ncbi.nlm.nih.gov/pubmed/36228754
http://dx.doi.org/10.1016/j.xphs.2022.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549718/
https://www.ncbi.nlm.nih.gov/pubmed/36228754
http://dx.doi.org/10.1016/j.xphs.2022.10.001

Ejemplares similares